‘No room for bad actors’ warns Althea boss by Steve Jones September 16, 2021September 17, 2021 Althea chief executive Josh Fegan has delivered a withering assessment of some industry players as he […]
Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea by Martin Lane September 2, 2021September 2, 2021
Althea completes A$10.64m capital raise and sets sights on ‘material growth’ by Steve Jones August 25, 2021August 26, 2021
Company news: Althea; Lifespot; Emyria; MGC Pharma; Incannex; RotoGro; Clever Leaves by Martin Lane July 28, 2021July 29, 2021
Althea launches ‘flexi’ range to win over price-sensitive patients by Martin Lane March 30, 2021March 30, 2021
Althea subsidiary Peak receives first order from Cronos Group by Martin Lane March 9, 2021March 9, 2021
